An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36941262.
- Also identified by DOI 10.1038/s41467-023-37035-5 and PMC identifier 10027274.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The main protease from SARS-CoV-2 (M<sup>pro</sup>) is responsible for cleavage of the viral polyprotein. M<sup>pro</sup> self-processing is called maturation, and it is crucial for enzyme dimerization and activity. Here we use C145S M<sup>pro</sup> to study the structure and dynamics of N-terminal cleavage in solution. Native mass spectroscopy analysis shows that mixed oligomeric states are composed of cleaved and uncleaved particles, indicating that N-terminal processing is not critical for dimerization. A 3.5 Å cryo-EM structure provides details of M<sup>pro</sup> N-terminal cleavage outside the constrains of crystal environment. We show that different classes of inhibitors shift the balance between oligomeric states. While non-covalent inhibitor MAT-POS-e194df51-1 prevents dimerization, the covalent inhibitor nirmatrelvir induces the conversion of monomers into dimers, even with intact N-termini. Our data indicates that the M<sup>pro</sup> dimerization is triggered by induced fit due to covalent linkage during substrate processing rather than the N-terminal processing.
Medical subject headings
- SARS-CoV-2
- Coronavirus 3C Proteases